Program #897 • Available April 12, 2011
Certified for AMA PRA Category 1 Credit™ through April 12, 2014

Optimizing Patient Care for Acute Coronary Snydromes: An Evidence-Based Approach

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI
Chief of Cardiology
VA Boston Healthcare System
Director, Integrated Interventional Cardiovascular Program
Brigham and Women's Hospital
Senior Investigator, TIMI Study Group
Harvard Medical School
Boston, Massachusetts

Program Description

Acute coronary syndromes (ACS), comprising unstable angina, non-ST-segment elevation myocardial infarction (UA/NSTEMI) and ST-segment elevation myocardial infarction (STEMI) present many challenges to hospital teams, including those with and without cardiac catheterization laboratories. For STEMI, rapid and accurate diagnosis and keeping the encounter time to reperfusion as short as possible is critical. For UA/NSTEMI, efficient risk stratification is important to select the appropriate treatment pathway and help guide management decisions. In this video, Dr. Bhatt reviews key recommendations from the 2007 UA/NSTEMI ACC/AHA Practice Guidelines and 2009 ACC/AHA Focused Updates for STEMI and PCI. Topic areas include reducing time to treatment, risk stratification, selection/timing/dosing of antithrombotic therapies in the emergency department, perioperative therapies for PCI, and long-term, secondary prevention recommendations. The role of evidence-based critical pathways to improve quality of patient care and optimize patient outcomes is emphasized throughout the lecture.

(60 minutes)

Method of Participation and Evaluation

To participate in this CME activity, please read the following information and click "Launch Program" at the bottom of this page. Complete the online evaluation at the conclusion of the activity. You may print your certificate immediately after completion of the evaluation. Please note: To view this program you need a computer with an Internet browser and audio and video capabilities.

Credit Information

Up to 1 AMA PRA Category 1 Credit

This activity is designed for cardiologists, emergency medicine physicians, hospitalists, internists, interventional cardiologists, and other healthcare providers with an interest in optimizing outcomes for patients with ACS.

Learning Objectives

After taking part in this CME activity, participants should be able to:

  • Implement current, evidence-based management strategies for STEMI and UA/NSTEMI
  • Develop and implement a pratical, systems-compatible, team approach to improving time to treatment in STEMI
  • Supplement the clinical evaluation of patients presenting with potential ACS using a validated risk tool such as the TIMI or GRACE risk score
  • Individualize antithrombotic therapy selection by considering patient characteristics, comorbidities, efficacy versus safety, dosing, and timing issues
  • Optimize secondary prevention efforts

Faculty Disclosures:

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, has received research support from Amarin Pharma Inc., AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eisai Inc., Ethicon Inc., Medtronic, Inc., sanofi-aventis, and The Medicines Company.

The Foundation for Improving Patient Outcomes staff and the independent peer reviewer report nothing to disclose.

CME Credit Designations

ACCME The Foundation for Improving Patient Outcomes (FFIPO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA FFIPO designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AOA This activity is eligible for up to 1 hour of credit in Category 2-A of the American Osteopathic Association.

Launch Program
Web Evaluation
Print Evaluation
Please login or create an account to access course. For more information, click here.